Stocktoria
IRADIMED CORP IRMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-07-16
IRADIMED CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $83.8M | $73.2M | $65.6M | $53.3M | $41.8M |
| Gross profit | $64.3M | $56.4M | $50.2M | $41.3M | $32.0M |
| R&D expense | $3.0M | $2.8M | $2.9M | $2.3M | $1.9M |
| Operating income | $26.1M | $22.0M | $20.0M | $15.6M | $9.8M |
| Income tax | $5.9M | $5.0M | $4.5M | $3.4M | $510,816 |
| Net income | $22.5M | $19.2M | $17.2M | $12.8M | $9.3M |
| EPS (diluted) | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 |
| Operating cash flow | $24.9M | $25.6M | $13.5M | $10.0M | $11.3M |
| Free cash flow | $17.2M | $17.6M | $6.0M | $9.2M | $10.8M |
| Cash & equivalents | $51.2M | $52.2M | $49.8M | $58.0M | $62.0M |
| Inventory | $11.6M | $10.4M | $12.8M | $5.4M | $4.3M |
| Total assets | $108.8M | $98.3M | $92.2M | $85.5M | $82.9M |
| Total liabilities | $14.2M | $11.5M | $20.7M | $11.8M | $10.7M |
| Shareholders' equity | $94.6M | $86.8M | $71.4M | $73.7M | $72.2M |
Source: SEC EDGAR filings · CIK 0001325618 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.